Axi-cel Retreatment in Relapsed/Refractory LBCL
NCT05800067
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
32
Enrollment
OTHER
Sponsor class
Conditions
CAR-T Retreatment
Interventions
DRUG:
axi-cel
Sponsor
Ruijin Hospital